\-\ Texto\\:\\ \ \(0\)\
\-\ bcva\\:\\ \\	od\\:\\ 20\\/70\\-1\\,\\ os\\:\\ 20\\/20\ \(0\)\
\-\ \\ v\\ a\\ near\\:\\	od\\:\\ 20\\/60\\-2\\,\\ os\\:\\ 20\\/20\ \(0\)\
\-\ \\ ta\\:\\ \\	\\	20\\,\\ 19\\ mm\\ hg\\ ou\ \(0\)\
\-\ \\ pupils\\:\\	2\\+\\ apd\\ od\\ \ \(0\)\
\-\ \\ stereo\\:\\ \\	\\(\\-\\)fly\ \(0\)\
\-\ \\ pip\\:\\	od\\:\\ 9\\/14\\,\\ os\\ 13\\/14\ \(0\)\
\-\ \\ mb\\:\\ \\	8\\ pd\\ et\\ at\\ distance\\ and\\ near\ \(0\)\
\-\ \\	\\	\\	normal\\ pursuits\\ and\\ saccades\ \(0\)\
\-\ \\ neuro\\:\\	no\\ other\\ cranial\\ nerve\\ deficits\\ and\\ otherwise\ \(0\)\
\-\ \\	\\	\\	neurologically\\ intact\ \(1\)\
\-\ \\ external\\:\\	no\\ ptosis\\ or\\ exophthalmos\ \(0\)\
\-\ \\ rest\\ of\\ exam\\ wnl\\,\\ except\\ \\.\\ \\.\\ \\.\ \(0\)\
\-\ absent\\ septum\\ pellucidum\ \(0\)\
\-\ atrophy\\ of\\ left\\ optic\\ nerve\ \(1\)\
\-\ septo\\-optic\\ dysplasia\ \(5\)\
\-\ congenital\\ maldevelopment\\/malformation\ \(0\)\
\-\ atypical\\ compression\\ \\(tumor\\ or\\ vascular\\ lesions\\)\\ of\\ the\\ optic\\ nerve\\,\\ chiasm\\ or\\ optic\\ tract\ \(0\)\
\-\ sequela\\ of\\ hydrocephalus\ \(0\)\
\-\ perinatal\\ hypoxia\ \(0\)\
\-\ vasculitis\ \(67\)\
\-\ atypical\\ optic\\ neuritis\ \(0\)\
\-\ non\\-organic\ \(0\)\
\-\ \\*initially\\ thought\\ she\\ might\\ have\\ cvd\\*\ \(0\)\
\-\ cc\\:\\ i\\ can\\‚\\Ä\\ôt\\ see\\ on\\ my\\ right\\ side\\ and\\ have\\ been\\ bumping\\ into\\ things\\ for\\ the\\ last\\ 1\\.5\\ years\\.\\ \ \(0\)\
\-\ referred\\ by\\ optometry\\ for\\ a\\ \\‚\\Ä\\úvisual\\ field\\ defect\\‚\\Ä\\ù\\ and\\ optic\\ nerve\\ abnormality\\ not\\ noted\\ prior\ \(0\)\
\-\ no\\ decline\\ in\\ central\\ vision\ \(0\)\
\-\ not\\ progressive\\ since\\ detected\\ by\\ the\\ patient\ \(0\)\
\-\ no\\ records\\ \\(no\\ baseline\\ va\\ \\,vf\\,\\ motility\\,\\ photos\\)\ \(0\)\
\-\ poh\\:\\	amblyopia\\/patching\\,\ \(0\)\
\-\ \\	\\	strabismus\\ surgery\\ at\\ age\\ 19\ \(1\)\
\-\ pmh\\:\\	narcolepsy\\,\\ fibromyalgia\\,\\ chronic\\ lower\ \(0\)\
\-\ \\	\\	back\\ pain\\,\\ tmj\ \(0\)\
\-\ fhx\\:\\	no\\ history\\ of\\ visual\\ or\\ cns\ \(0\)\
\-\ \\	\\	disease\ \(1\)\
\-\ septo\\-optic\\ dysplasia\\,\\(de\\ morsier\\ syndrome\\)\\,radiographic\\ features\\:\ \(0\)\
\-\ disorder\\ of\\ midline\\ prosencephalic\\ cleavage\ \(0\)\
\-\ incomplete\\ development\\ \\ \\(or\\ absence\\)\\ of\\ the\\ \\ septum\\ pellucidum\ \(0\)\
\-\ uni\\/bilateral\\ optic\\ nerve\\,\\ chiasm\\,\\ optic\\ tract\\ dysplasia\ \(0\)\
\-\ \\+\\/\\-\\ malformation\\ of\\ the\\ corpus\\ callosum\\ and\\ fornix\\,\\ large\\ chiasmatic\\ cistern\\,\\ schizencephaly\ \(0\)\
\-\ \\*\\*\\*\\*\\*\\*\\*when\\ characteristic\\ facial\\ dysmorphism\\,\\ open\\ anterior\\ fontanel\\,\\ and\\ other\\ features\\ are\\ present\\ along\\ with\\ septo\\-optic\\ dysplasia\\,\\ the\\ term\\ de\\ morsier\\ syndrome\\ is\\ used\\,\\ although\\ in\\ common\\ parlance\\ this\\ term\\ is\\ used\\ interchangably\\ with\\ septo\\-optic\\ dysplasia\\,\\ whether\\ or\\ not\\ other\\ features\\ are\\ present\\.\ \(0\)\
\-\ clinical\\ features\\:\ \(0\)\
\-\ pendular\\ nystagmus\ \(0\)\
\-\ visual\\ disturbance\ \(13\)\
\-\ mental\\ retardation\\ \ \(4\)\
\-\ hemiparesis\\ \\(especially\\ if\\ associated\\ with\\ schizencephaly\\)\ \(0\)\
\-\ quadriparesis\ \(2\)\
\-\ hypopituitarism\\ in\\ 15\\-60\\%\\ \ \(0\)\
\-\ triad\\ of\\ a\\ small\\ anterior\\ pituitary\\ gland\\,\\ an\\ attenuated\\ pituitary\\ stalk\\,\\ and\\ an\\ ectopic\\ posterior\\ pituitary\\ enhancement\\ \\(\\‚\\Ä\\úbright\\ spot\\‚\\Ä\\ù\\)\\ on\\ mri\\ \ \(0\)\
\-\ endocrine\\ defects\\ range\\ from\\ panhypopituitarism\\ to\\ isolated\\ deficiencies\\ of\\ acth\\,\\ gh\\,\\ tsh\\,\\ adh\\ or\\ gonadotropins\\ \\(delayed\\ puberty\\)\ \(0\)\
\-\ may\\ have\\ isolated\\ hyperprolactinemia\\ or\\ precocious\\ puberty\\ \ \(0\)\
\-\ neonatal\\ hypoglycemia\\ and\\ seizures\\ are\\ important\\ presenting\\ signs\\ in\\ affected\\ infants\ \(0\)\
\-\ \\*\\*\\*\\*evaluation\\ of\\ the\\ hypothalamic\\‚\\Ä\\ìpituitary\\ axis\\‚\\Ä\\îpot\\‚\\Ä\\ôl\\ life\\-threatening\\ in\\ infancy\\*\\*\\*\\*\ \(0\)\
\-\ elevation\\ of\\ prolactin\\ with\\ lack\\ of\\ hypothalamic\\ inhibition\ \(0\)\
\-\ precocious\\ puberty\\ with\\ imbalance\\ of\\ pituitary\\ precursor\\ cells\ \(0\)\
\-\ etiology\\:\\ \ \(1\)\
\-\ sporadic\ \(26\)\
\-\ mutation\\ in\\ the\\ hesx1\\ homeobox\\ gene\ \(0\)\
\-\ young\\ maternal\\ age\ \(0\)\
\-\ pregnancy\\ risk\\ factors\\:\ \(0\)\
\-\ diabetes\ \(101\)\
\-\ anticonvulsants\ \(2\)\
\-\ phencyclidine\ \(0\)\
\-\ cocaine\\ \ \(8\)\
\-\ alcohol\ \(122\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\*\\:\\ 0\\.16946809649505523\ \(0\)\
\-\ optic\\:\\ 0\\.058050193159819255\ \(0\)\
\-\ septo\\-optic\\:\\ 0\\.053086891188079646\ \(0\)\
\-\ \\:\\:\\ 0\\.052130075370638636\ \(0\)\
\-\ od\\:\\ 0\\.049686764495348715\ \(0\)\
\-\ puberty\\:\\ 0\\.038411749829335144\ \(0\)\
\-\ pituitary\\:\\ 0\\.035915462732186515\ \(0\)\
\-\ dysplasia\\:\\ 0\\.03535744982646441\ \(0\)\
\-\ morsier\\:\\ 0\\.03405606391365431\ \(0\)\
\-\ nerve\\:\\ 0\\.032274068411816625\ \(0\)\
\-\ os\\:\\ 0\\.03208771293875592\ \(0\)\
\-\ features\\:\\ 0\\.030239264328092895\ \(0\)\
\-\ precocious\\:\\ 0\\.02774965973429886\ \(0\)\
\-\ 20\\/20\\:\\ 0\\.02690827317051626\ \(0\)\
\-\ schizencephaly\\:\\ 0\\.024616685303144897\ \(0\)\
\-\ visual\\:\\ 0\\.02436400000853581\ \(0\)\
\-\ de\\:\\ 0\\.0238156151280392\ \(0\)\
\-\ pellucidum\\:\\ 0\\.022701555732932255\ \(0\)\
\-\ chiasm\\:\\ 0\\.021290770673723813\ \(0\)\
\-\ isolated\\:\\ 0\\.018641805331234704\ \(0\)\
\-\ 20\\/70\\-1\\:\\ 0\\.01848117070013941\ \(0\)\
\-\ 20\\/60\\-2\\:\\ 0\\.01848117070013941\ \(0\)\
\-\ 9\\/14\\:\\ 0\\.01848117070013941\ \(0\)\
\-\ 13\\/14\\:\\ 0\\.01848117070013941\ \(0\)\
\-\ maldevelopment\\/malformation\\:\\ 0\\.01848117070013941\ \(0\)\
\-\ non\\-organic\\:\\ 0\\.01848117070013941\ \(0\)\
\-\ cvd\\:\\ 0\\.01848117070013941\ \(0\)\
\-\ poh\\:\\ 0\\.01848117070013941\ \(0\)\
\-\ amblyopia\\/patching\\:\\ 0\\.01848117070013941\ \(0\)\
\-\ narcolepsy\\:\\ 0\\.01848117070013941\ \(0\)\
\-\ prosencephalic\\:\\ 0\\.01848117070013941\ \(0\)\
\-\ uni\\/bilateral\\:\\ 0\\.01848117070013941\ \(0\)\
\-\ parlance\\:\\ 0\\.01848117070013941\ \(0\)\
\-\ interchangably\\:\\ 0\\.01848117070013941\ \(0\)\
\-\ pendular\\:\\ 0\\.01848117070013941\ \(0\)\
\-\ 15\\-60\\:\\ 0\\.01848117070013941\ \(0\)\
\-\ gonadotropins\\:\\ 0\\.01848117070013941\ \(0\)\
\-\ hypothalamic\\‚\\Ä\\ìpituitary\\:\\ 0\\.01848117070013941\ \(0\)\
\-\ axis\\‚\\Ä\\îpot\\:\\ 0\\.01848117070013941\ \(0\)\
\-\ inhibition\\:\\ 0\\.01848117070013941\ \(0\)\
\-\ hesx1\\:\\ 0\\.01848117070013941\ \(0\)\
\-\ homeobox\\:\\ 0\\.01848117070013941\ \(0\)\
\-\ phencyclidine\\:\\ 0\\.01848117070013941\ \(0\)\
\-\ septum\\:\\ 0\\.01833487281960663\ \(0\)\
\-\ bcva\\:\\ 0\\.017028031956827155\ \(0\)\
\-\ stereo\\:\\ 0\\.017028031956827155\ \(0\)\
\-\ bumping\\:\\ 0\\.017028031956827155\ \(0\)\
\-\ or\\:\\ 0\\.016797027236288595\ \(0\)\
\-\ 19\\:\\ 0\\.01652126247700355\ \(0\)\
\-\ \\,\\:\\ 0\\.016458263941302585\ \(0\)\
\-\ term\\:\\ 0\\.01639515155357681\ \(0\)\
\-\ apd\\:\\ 0\\.016178000283644422\ \(0\)\
\-\ pursuits\\:\\ 0\\.016178000283644422\ \(0\)\
\-\ optometry\\:\\ 0\\.016178000283644422\ \(0\)\
\-\ vf\\:\\ 0\\.016178000283644422\ \(0\)\
\-\ strabismus\\:\\ 0\\.016178000283644422\ \(0\)\
\-\ quadriparesis\\:\\ 0\\.016178000283644422\ \(0\)\
\-\ panhypopituitarism\\:\\ 0\\.016178000283644422\ \(0\)\
\-\ anticonvulsants\\:\\ 0\\.016178000283644422\ \(0\)\
\-\ tract\\:\\ 0\\.015870358501358754\ \(0\)\
\-\ fly\\:\\ 0\\.015574893213514901\ \(0\)\
\-\ mb\\:\\ 0\\.015574893213514901\ \(0\)\
\-\ saccades\\:\\ 0\\.015574893213514901\ \(0\)\
\-\ photos\\:\\ 0\\.015574893213514901\ \(0\)\
\-\ cleavage\\:\\ 0\\.015574893213514901\ \(0\)\
\-\ fornix\\:\\ 0\\.015574893213514901\ \(0\)\
\-\ dysmorphism\\:\\ 0\\.015574893213514901\ \(0\)\
\-\ adh\\:\\ 0\\.015574893213514901\ \(0\)\
\-\ life\\-threatening\\:\\ 0\\.015574893213514901\ \(0\)\
\-\ atypical\\:\\ 0\\.015528430337987235\ \(0\)\
\-\ near\\:\\ 0\\.015503247847168736\ \(0\)\
\-\ chiasmatic\\:\\ 0\\.015107087026273372\ \(0\)\
\-\ fontanel\\:\\ 0\\.015107087026273372\ \(0\)\
\-\ hypopituitarism\\:\\ 0\\.015107087026273372\ \(0\)\
\-\ hyperprolactinemia\\:\\ 0\\.015107087026273372\ \(0\)\
\-\ imbalance\\:\\ 0\\.015107087026273372\ \(0\)\
\-\ perinatal\\:\\ 0\\.014724861540332167\ \(0\)\
\-\ fibromyalgia\\:\\ 0\\.014724861540332167\ \(0\)\
\-\ tmj\\:\\ 0\\.014724861540332167\ \(0\)\
\-\ deficiencies\\:\\ 0\\.014724861540332167\ \(0\)\
\-\ gh\\:\\ 0\\.014724861540332167\ \(0\)\
\-\ ta\\:\\ 0\\.014401694496669152\ \(0\)\
\-\ ou\\:\\ 0\\.014401694496669152\ \(0\)\
\-\ precursor\\:\\ 0\\.014401694496669152\ \(0\)\
\-\ fhx\\:\\ 0\\.014121754470202646\ \(0\)\
\-\ cocaine\\:\\ 0\\.014121754470202646\ \(0\)\
\-\ hypoglycemia\\:\\ 0\\.01387482986714943\ \(0\)\
\-\ used\\:\\ 0\\.01374500694737091\ \(0\)\
\-\ va\\:\\ 0\\.013653948282961117\ \(0\)\
\-\ acth\\:\\ 0\\.013653948282961117\ \(0\)\
\-\ neurologically\\:\\ 0\\.01345413658525813\ \(0\)\
\-\ \\‚\\Ä\\ú\\:\\ 0\\.013381555210814088\ \(0\)\
\-\ \\‚\\Ä\\ù\\:\\ 0\\.013306546553578132\ \(0\)\
\-\ things\\:\\ 0\\.013271722797019912\ \(0\)\
\-\ exophthalmos\\:\\ 0\\.01310391837841711\ \(0\)\
\-\ records\\:\\ 0\\.01310391837841711\ \(0\)\
\-\ attenuated\\:\\ 0\\.01310391837841711\ \(0\)\
\-\ infancy\\:\\ 0\\.01310391837841711\ \(0\)\
\-\ motility\\:\\ 0\\.012948555753356896\ \(0\)\
\-\ sequela\\:\\ 0\\.012803916609778383\ \(0\)\
\-\ disturbance\\:\\ 0\\.012803916609778383\ \(0\)\
\-\ prolactin\\:\\ 0\\.012803916609778383\ \(0\)\
\-\ pd\\:\\ 0\\.012541520083669355\ \(0\)\
\-\ hg\\:\\ 0\\.012421691123837179\ \(0\)\
\-\ ptosis\\:\\ 0\\.012421691123837179\ \(0\)\
\-\ my\\:\\ 0\\.012421691123837179\ \(0\)\
\-\ other\\:\\ 0\\.012387663828317288\ \(0\)\
\-\ \\+\\/\\-\\:\\ 0\\.012200809539648862\ \(0\)\
\-\ \\(\\:\\ 0\\.01211508136258047\ \(0\)\
\-\ pip\\:\\ 0\\.012098524080174162\ \(0\)\
\-\ retardation\\:\\ 0\\.012098524080174162\ \(0\)\
\-\ triad\\:\\ 0\\.012098524080174162\ \(0\)\
\-\ decline\\:\\ 0\\.012000997841945875\ \(0\)\
\-\ gene\\:\\ 0\\.012000997841945875\ \(0\)\
\-\ \\)\\:\\ 0\\.011967089175904489\ \(0\)\
\-\ stalk\\:\\ 0\\.011818584053707656\ \(0\)\
\-\ hypothalamic\\:\\ 0\\.011818584053707656\ \(0\)\
\-\ have\\:\\ 0\\.011637975335629509\ \(0\)\
\-\ sporadic\\:\\ 0\\.011571659450654444\ \(0\)\
\-\ mutation\\:\\ 0\\.011421850301844914\ \(0\)\
\-\ hypoxia\\:\\ 0\\.011350777866466127\ \(0\)\
\-\ neuritis\\:\\ 0\\.011350777866466127\ \(0\)\
\-\ nystagmus\\:\\ 0\\.011282036099541618\ \(0\)\
\-\ maternal\\:\\ 0\\.011282036099541618\ \(0\)\
\-\ hemiparesis\\:\\ 0\\.01115096616876314\ \(0\)\
\-\ endocrine\\:\\ 0\\.011088381340357101\ \(0\)\
\-\ age\\:\\ 0\\.01090528438383357\ \(0\)\
\-\ no\\:\\ 0\\.010823196864198768\ \(0\)\
\-\ distance\\:\\ 0\\.010800747961922123\ \(0\)\
\-\ neonatal\\:\\ 0\\.010747670796336609\ \(0\)\
\-\ \\‚\\Ä\\ô\\:\\ 0\\.010708707503754532\ \(0\)\
\-\ baseline\\:\\ 0\\.010596055153612024\ \(0\)\
\-\ infants\\:\\ 0\\.01040958243659631\ \(0\)\
\-\ syndrome\\:\\ 0\\.010246987743122188\ \(0\)\
\-\ might\\:\\ 0\\.010157707569002887\ \(0\)\
\-\ v\\:\\ 0\\.009828897356229365\ \(0\)\
\-\ pupils\\:\\ 0\\.009795353663679174\ \(0\)\
\-\ tsh\\:\\ 0\\.009729834704551072\ \(0\)\
\-\ incomplete\\:\\ 0\\.009666301477097553\ \(0\)\
\-\ whether\\:\\ 0\\.009635242597044846\ \(0\)\
\-\ spot\\:\\ 0\\.009635242597044846\ \(0\)\
\-\ cc\\:\\ 0\\.00960463714752461\ \(0\)\
\-\ cistern\\:\\ 0\\.009574472079490857\ \(0\)\
\-\ detected\\:\\ 0\\.009457973439753308\ \(0\)\
\-\ neuro\\:\\ 0\\.009242765569606385\ \(0\)\
\-\ atrophy\\:\\ 0\\.009242765569606385\ \(0\)\
\-\ anterior\\:\\ 0\\.009227642866929717\ \(0\)\
\-\ wnl\\:\\ 0\\.009192246593549653\ \(0\)\
\-\ field\\:\\ 0\\.009192246593549653\ \(0\)\
\-\ callosum\\:\\ 0\\.009192246593549653\ \(0\)\
\-\ 2\\+\\:\\ 0\\.009167436409803316\ \(0\)\
\-\ vasculitis\\:\\ 0\\.009167436409803316\ \(0\)\
\-\ cns\\:\\ 0\\.009167436409803316\ \(0\)\
\-\ except\\:\\ 0\\.009071031560239745\ \(0\)\
\-\ alcohol\\:\\ 0\\.009024442174946853\ \(0\)\
\-\ 1\\.5\\:\\ 0\\.008956443693284057\ \(0\)\
\-\ bright\\:\\ 0\\.008956443693284057\ \(0\)\
\-\ pmh\\:\\ 0\\.00891230656708315\ \(0\)\
\-\ diabetes\\:\\ 0\\.008869079549886638\ \(0\)\
\-\ elevation\\:\\ 0\\.008847795752268153\ \(0\)\
\-\ corpus\\:\\ 0\\.008826725865782823\ \(0\)\
\-\ ectopic\\:\\ 0\\.008589139523420133\ \(0\)\
\-\ mental\\:\\ 0\\.008358919678541294\ \(0\)\
\-\ t\\:\\ 0\\.008292884737117036\ \(0\)\
\-\ vision\\:\\ 0\\.008276695961238817\ \(0\)\
\-\ rest\\:\\ 0\\.008260631238501775\ \(0\)\
\-\ thought\\:\\ 0\\.008244688682138632\ \(0\)\
\-\ defects\\:\\ 0\\.00822886644810219\ \(0\)\
\-\ deficits\\:\\ 0\\.008197575776788405\ \(0\)\
\-\ l\\:\\ 0\\.008166745279116087\ \(0\)\
\-\ lack\\:\\ 0\\.008151498404212356\ \(0\)\
\-\ present\\:\\ 0\\.008092279890698871\ \(0\)\
\-\ disorder\\:\\ 0\\.008047766627978877\ \(0\)\
\-\ important\\:\\ 0\\.008047766627978877\ \(0\)\
\-\ factors\\:\\ 0\\.008047766627978877\ \(0\)\
\-\ open\\:\\ 0\\.007962764333651099\ \(0\)\
\-\ development\\:\\ 0\\.00780244910515668\ \(0\)\
\-\ young\\:\\ 0\\.00780244910515668\ \(0\)\
\-\ cranial\\:\\ 0\\.0077896268262941295\ \(0\)\
\-\ facial\\:\\ 0\\.0077896268262941295\ \(0\)\
\-\ not\\:\\ 0\\.0077661551681882735\ \(0\)\
\-\ absent\\:\\ 0\\.007764215168993617\ \(0\)\
\-\ affected\\:\\ 0\\.007751623923584368\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.00770200181858247\ \(0\)\
\-\ seizures\\:\\ 0\\.00770200181858247\ \(0\)\
\-\ pregnancy\\:\\ 0\\.00770200181858247\ \(0\)\
\-\ last\\:\\ 0\\.007653527148937075\ \(0\)\
\-\ gland\\:\\ 0\\.0076297037555401875\ \(0\)\
\-\ external\\:\\ 0\\.007617892816927491\ \(0\)\
\-\ characteristic\\:\\ 0\\.007582854072747742\ \(0\)\
\-\ etiology\\:\\ 0\\.007582854072747742\ \(0\)\
\-\ absence\\:\\ 0\\.00744827722235139\ \(0\)\
\-\ i\\:\\ 0\\.00740527189775369\ \(0\)\
\-\ especially\\:\\ 0\\.007373587122470569\ \(0\)\
\-\ et\\:\\ 0\\.007332072180549857\ \(0\)\
\-\ are\\:\\ 0\\.007326250770626427\ \(0\)\
\-\ presenting\\:\\ 0\\.007301466731029621\ \(0\)\
\-\ initially\\:\\ 0\\.007291363405168093\ \(0\)\
\-\ delayed\\:\\ 0\\.007291363405168093\ \(0\)\
\-\ range\\:\\ 0\\.0072122432207176795\ \(0\)\
\-\ cells\\:\\ 0\\.007183326402830184\ \(0\)\
\-\ malformation\\:\\ 0\\.007145380822864527\ \(0\)\
\-\ progressive\\:\\ 0\\.007080585146841306\ \(0\)\
\-\ midline\\:\\ 0\\.006931090329850149\ \(0\)\
\-\ radiographic\\:\\ 0\\.0067995060624501755\ \(0\)\
\-\ referred\\:\\ 0\\.006760023990473043\ \(0\)\
\-\ compression\\:\\ 0\\.006705969237526052\ \(0\)\
\-\ defect\\:\\ 0\\.006705969237526052\ \(0\)\
\-\ 8\\:\\ 0\\.006698359660900101\ \(0\)\
\-\ abnormality\\:\\ 0\\.00660913615058816\ \(0\)\
\-\ mm\\:\\ 0\\.006587411230178209\ \(0\)\
\-\ intact\\:\\ 0\\.006580219332700664\ \(0\)\
\-\ since\\:\\ 0\\.006580219332700664\ \(0\)\
\-\ congenital\\:\\ 0\\.0065516959531288005\ \(0\)\
\-\ risk\\:\\ 0\\.006488902824652173\ \(0\)\
\-\ 20\\:\\ 0\\.006441331731985358\ \(0\)\
\-\ otherwise\\:\\ 0\\.006434623130872841\ \(0\)\
\-\ signs\\:\\ 0\\.006304771350075586\ \(0\)\
\-\ side\\:\\ 0\\.0062063867961510925\ \(0\)\
\-\ although\\:\\ 0\\.006050166206659547\ \(0\)\
\-\ by\\:\\ 0\\.005965915736875786\ \(0\)\
\-\ along\\:\\ 0\\.005920448379158315\ \(0\)\
\-\ back\\:\\ 0\\.005909992317290309\ \(0\)\
\-\ central\\:\\ 0\\.005894405360293416\ \(0\)\
\-\ vascular\\:\\ 0\\.005873801400259323\ \(0\)\
\-\ clinical\\:\\ 0\\.00551217987435221\ \(0\)\
\-\ see\\:\\ 0\\.005346367319137921\ \(0\)\
\-\ in\\:\\ 0\\.005300594089814528\ \(0\)\
\-\ years\\:\\ 0\\.005260467792491578\ \(0\)\
\-\ evaluation\\:\\ 0\\.005203854917875907\ \(0\)\
\-\ when\\:\\ 0\\.005130673454121605\ \(0\)\
\-\ chronic\\:\\ 0\\.005046099859343816\ \(0\)\
\-\ she\\:\\ 0\\.0050289017640548685\ \(0\)\
\-\ an\\:\\ 0\\.004954569661571194\ \(0\)\
\-\ been\\:\\ 0\\.004873783835354279\ \(0\)\
\-\ if\\:\\ 0\\.004861097345452066\ \(0\)\
\-\ at\\:\\ 0\\.004854352842061355\ \(0\)\
\-\ enhancement\\:\\ 0\\.004801863241348084\ \(0\)\
\-\ lesions\\:\\ 0\\.0047957243319579615\ \(0\)\
\-\ common\\:\\ 0\\.004688191220034376\ \(0\)\
\-\ prior\\:\\ 0\\.004599817132499714\ \(0\)\
\-\ surgery\\:\\ 0\\.004350102860294078\ \(0\)\
\-\ into\\:\\ 0\\.00426273871689666\ \(0\)\
\-\ noted\\:\\ 0\\.00424616601352745\ \(0\)\
\-\ associated\\:\\ 0\\.00422738482580231\ \(0\)\
\-\ \\%\\:\\ 0\\.004178870090872134\ \(0\)\
\-\ tumor\\:\\ 0\\.0041765876344042165\ \(0\)\
\-\ posterior\\:\\ 0\\.004129221276105762\ \(0\)\
\-\ small\\:\\ 0\\.004126992210442597\ \(0\)\
\-\ mri\\:\\ 0\\.00411588229541849\ \(0\)\
\-\ can\\:\\ 0\\.004063359229494905\ \(0\)\
\-\ lower\\:\\ 0\\.004029060942062605\ \(0\)\
\-\ exam\\:\\ 0\\.003935500922326076\ \(0\)\
\-\ may\\:\\ 0\\.003929409578402775\ \(0\)\
\-\ large\\:\\ 0\\.003917279731302054\ \(0\)\
\-\ \\-\\:\\ 0\\.0038401015905835715\ \(0\)\
\-\ of\\:\\ 0\\.003419398765559409\ \(0\)\
\-\ and\\:\\ 0\\.003396396334570159\ \(0\)\
\-\ for\\:\\ 0\\.0030570572270134807\ \(0\)\
\-\ on\\:\\ 0\\.003035182441783766\ \(0\)\
\-\ disease\\:\\ 0\\.0029281709459448727\ \(0\)\
\-\ normal\\:\\ 0\\.002808411854505453\ \(0\)\
\-\ from\\:\\ 0\\.0026550014950822063\ \(0\)\
\-\ a\\:\\ 0\\.0024943383762176183\ \(0\)\
\-\ history\\:\\ 0\\.002474244313851328\ \(0\)\
\-\ is\\:\\ 0\\.0023576133265606944\ \(0\)\
\-\ the\\:\\ 0\\.00231864628433754\ \(0\)\
\-\ pain\\:\\ 0\\.0021878577935654816\ \(0\)\
\-\ this\\:\\ 0\\.002014962711350384\ \(0\)\
\-\ left\\:\\ 0\\.0020044135624170123\ \(0\)\
\-\ right\\:\\ 0\\.001890213226646576\ \(0\)\
\-\ patient\\:\\ 0\\.0017957902115647547\ \(0\)\
\-\ with\\:\\ 0\\.0012264588688667688\ \(0\)\
\-\ to\\:\\ 0\\.0008953209820607679\ \(0\)\
\-\ \\.\\:\\ 0\\.00037211253770803225\ \(0\)\
